A phase II study of the combination of bevacizumab with cytotoxic chemotherapy, as first line treatment, in older patients with advanced/metastatic NSCLC (non-squamous)
Titel:
A phase II study of the combination of bevacizumab with cytotoxic chemotherapy, as first line treatment, in older patients with advanced/metastatic NSCLC (non-squamous)
Auteur:
Pallis, A.G. Vamvakas, L. Karampeazis, A. Polyzos, A. Agelaki, S. Kentepozidis, N. Boukovinas, I. Kotsakis, A. Papadimitraki, E. Koinis, F. Georgoulias, V.